4D Molecular Therapeutics
About:
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Website: http://www.4dmoleculartherapeutics.com
Twitter/X: 4dmolecular
Top Investors: Perceptive Advisors, Biotechnology Value Fund, Mirae Asset, Viking Global Investors, Casdin Capital
Description:
4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Total Funding Amount:
$595M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Emeryville, California, United States
Founded Date:
2013-01-01
Founders:
David Kirn, David Schaffer, Theresa Janke
Number of Employees:
101-250
Last Funding Date:
2024-02-06
IPO Status:
Public
Industries:
© 2025 bioDAO.ai